• Careers
  • Investors
  • News
  • Partnering
  • Contact Us
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Product Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • News
    • All News
    • Corporate News
    • Product And Operating Company News
    • Financial News
    • Media Contacts
    • All News Archive
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

< Prev | | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | .... 39 Next >
New Research Shows Minimally Invasive, Video-Assisted Thorascopic Lobectomies For Lung Cancer More Cost Effective And Clinically Beneficial Than Traditional, Open Surgery

May 09, 2012

Janssen Research & Development Submits Supplemental New Drug Application To U.S. FDA For XARELTO® (rivaroxaban) To Reduce The Risk Of Stent Thrombosis In Patients With Acute Coronary Syndrome

May 09, 2012

Leading Authority On Eye Allergies Shares Tips, Offers Advice For Eye Allergy Sufferers On New Edition Of Healthy Vision™ With Dr. Val Jones

May 08, 2012

Johnson & Johnson to Participate In 2012 Deutsche Bank Securities, Inc. 37th Annual Health Care Conference

May 02, 2012

Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotech Co., Ltd.

May 02, 2012

Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism

May 02, 2012

< Prev | | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | .... 39 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partnering
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • All News
  • Corporate News
  • Product And Operating Company News
  • Financial News
  • Media Contacts
  • All News Archive
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

All News

Find press releases issued in the past two years issued by Johnson & Johnson corporate headquarters and our operating companies.

< Prev | | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | .... 39 Next >
New Research Shows Minimally Invasive, Video-Assisted Thorascopic Lobectomies For Lung Cancer More Cost Effective And Clinically Beneficial Than Traditional, Open Surgery

May 09, 2012

Janssen Research & Development Submits Supplemental New Drug Application To U.S. FDA For XARELTO® (rivaroxaban) To Reduce The Risk Of Stent Thrombosis In Patients With Acute Coronary Syndrome

May 09, 2012

Leading Authority On Eye Allergies Shares Tips, Offers Advice For Eye Allergy Sufferers On New Edition Of Healthy Vision™ With Dr. Val Jones

May 08, 2012

Johnson & Johnson to Participate In 2012 Deutsche Bank Securities, Inc. 37th Annual Health Care Conference

May 02, 2012

Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotech Co., Ltd.

May 02, 2012

Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism

May 02, 2012

< Prev | | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | .... 39 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •